Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewVU 6005649 is a positive allosteric modulator of mGlu7 and mGlu8 receptors (EC50 = 0.65 μM and 2.6 μM for mGlu7 and mGlu8, respectively). Displays >3.8 fold selectivity for mGlu7 and mGlu8 over other mGlu receptors (EC50 >10 μM for mGlu1,2,3,4,5,6). Also NK1 receptor antagonist (Ki= 650 nM, IC50 = 3.4 μM). Brain penetrant.
VU 6005649 is also offered as part of the Tocriscreen 2.0 Max. Find out more about compound libraries available from Tocris.
M. Wt | 357.28 |
Formula | C16H12F5N3O |
Storage | Store at -20°C |
Purity | ≥98% (HPLC) |
CAS Number | 2137047-43-7 |
PubChem ID | 131954513 |
InChI Key | NYBZCKAQIIPSDS-UHFFFAOYSA-N |
Smiles | COC1=C(F)C(F)=C(C=C1)C1=C2N=C(C)C=C(N2N=C1C)C(F)(F)F |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solvent | Max Conc. mg/mL | Max Conc. mM | |
---|---|---|---|
Solubility | |||
DMSO | 35.73 | 100 | |
ethanol | 17.86 | 50 |
The following data is based on the product molecular weight 357.28. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 2.8 mL | 13.99 mL | 27.99 mL |
5 mM | 0.56 mL | 2.8 mL | 5.6 mL |
10 mM | 0.28 mL | 1.4 mL | 2.8 mL |
50 mM | 0.06 mL | 0.28 mL | 0.56 mL |
References are publications that support the biological activity of the product.
Abe et al (2017) Discovery of VU6005649, a CNS penetrant mGlu7/8 receptor PAM derived from a series of pyrazolo[1,5-a]pyrimidines. ACS.Med.Chem.Lett. 8 1110 PMID: 29057060
If you know of a relevant reference for VU 6005649, please let us know.
View all Glutamate (Metabotropic) Group III Receptor Modulators
Keywords: VU 6005649, VU 6005649 supplier, VU6005649, positive, allosteric, modulators, modulates, PAM, metabotropic, glutamate, receptor, 7, 8, group, III, mGlu, neurokinin, 1, antagonists, antagonism, tachykinin, NK1, Glutamate, (Metabotropic), Group, Receptors, Receptor, 6893, Tocris Bioscience
Citations are publications that use Tocris products.
Currently there are no citations for VU 6005649. Do you know of a great paper that uses VU 6005649 from Tocris? Please let us know.
There are currently no reviews for this product. Be the first to review VU 6005649 and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
The key feature of drug addiction is the inability to stop using a drug despite clear evidence of harm. This poster describes the brain circuits associated with addiction, and provides an overview of the main classes of addictive drugs and the neurotransmitter systems that they target.
Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.